Egetis Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Egetis Therapeutics has a total shareholder equity of SEK545.6M and total debt of SEK108.6M, which brings its debt-to-equity ratio to 19.9%. Its total assets and total liabilities are SEK760.2M and SEK214.6M respectively.
Key information
19.9%
Debt to equity ratio
kr108.60m
Debt
Interest coverage ratio | n/a |
Cash | kr303.30m |
Equity | kr545.60m |
Total liabilities | kr214.60m |
Total assets | kr760.20m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: P0F's short term assets (SEK345.9M) exceed its short term liabilities (SEK103.9M).
Long Term Liabilities: P0F's short term assets (SEK345.9M) exceed its long term liabilities (SEK110.7M).
Debt to Equity History and Analysis
Debt Level: P0F has more cash than its total debt.
Reducing Debt: P0F's debt to equity ratio has increased from 0% to 19.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: P0F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: P0F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 22.6% each year